Insight Molecular Diagnostics Inc. (IMDX) Tops Q2 EPS by 1c

Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $240 thousand versus the consensus estimate of $470.85 thousand.

For earnings history and earnings-related data on Insight Molecular Diagnostics Inc. (IMDX) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Alabama Power Co. 5.875% Sr. Notes Series 2007b (ALM) Tops Q2 EPS by 62c
• Barclays Upgrades Arkema SA (AKE:FP) (ARKAF) to Equalweight